218 related articles for article (PubMed ID: 18062776)
21. The TGF mechanism is not needed for development of glomerular hyperfiltration in diabetes.
Skøtt O
Acta Physiol (Oxf); 2007 Jul; 190(3):177. PubMed ID: 17581132
[No Abstract] [Full Text] [Related]
22. The clinical significance of hyperfiltration in diabetes.
Jerums G; Premaratne E; Panagiotopoulos S; MacIsaac RJ
Diabetologia; 2010 Oct; 53(10):2093-104. PubMed ID: 20496053
[TBL] [Abstract][Full Text] [Related]
23. Rodent models of streptozotocin-induced diabetic nephropathy.
Tesch GH; Allen TJ
Nephrology (Carlton); 2007 Jun; 12(3):261-6. PubMed ID: 17498121
[TBL] [Abstract][Full Text] [Related]
24. Deletion of MK2 signalling in vivo inhibits small Hsp phosphorylation but not diabetic nephropathy.
Park JK; Ronkina N; Höft A; Prohl C; Menne J; Gaestel M; Haller H; Meier M
Nephrol Dial Transplant; 2008 Jun; 23(6):1844-53. PubMed ID: 18182404
[TBL] [Abstract][Full Text] [Related]
25. Between hyperfiltration and impairment: demystifying early renal functional changes in diabetic nephropathy.
Rosolowsky ET; Niewczas MA; Ficociello LH; Perkins BA; Warram JH; Krolewski AS
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S46-53. PubMed ID: 18849087
[TBL] [Abstract][Full Text] [Related]
26. Primary kidney growth and its consequences at the onset of diabetes mellitus.
Satriano J; Vallon V
Amino Acids; 2006 Jul; 31(1):1-9. PubMed ID: 16733619
[TBL] [Abstract][Full Text] [Related]
27. Toward a mouse model of diabetic nephropathy: is endothelial nitric oxide synthase the missing link?
Quaggin SE; Coffman TM
J Am Soc Nephrol; 2007 Feb; 18(2):364-6. PubMed ID: 17259594
[No Abstract] [Full Text] [Related]
28. A novel mouse model of advanced diabetic kidney disease.
Thibodeau JF; Holterman CE; Burger D; Read NC; Reudelhuber TL; Kennedy CR
PLoS One; 2014; 9(12):e113459. PubMed ID: 25514595
[TBL] [Abstract][Full Text] [Related]
29. [Dual role of nitric oxide in the pathogenesis of diabetic nephropathy].
Ksiazek K; Witowski J
Przegl Lek; 2002; 59(3):153-7. PubMed ID: 12184028
[TBL] [Abstract][Full Text] [Related]
30. The current clinical problems for early phase of diabetic nephropathy and approach for pathogenesis of diabetic nephropathy.
Doi T; Mima A; Matsubara T; Tominaga T; Arai H; Abe H
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S21-4. PubMed ID: 18842318
[TBL] [Abstract][Full Text] [Related]
31. Is the Hp 2-2 diabetic mouse model a good model to study diabetic nephropathy?
Nakhoul F; Nakhoul N; Asleh R; Miller-Lotan R; Levy AP
Diabetes Res Clin Pract; 2013 Jun; 100(3):289-97. PubMed ID: 23490597
[TBL] [Abstract][Full Text] [Related]
32. [Hyperfiltration].
Kaida Y; Ueda S; Okuda S
Nihon Rinsho; 2010 Nov; 68 Suppl 9():385-9. PubMed ID: 21667491
[No Abstract] [Full Text] [Related]
33. [Glomerular hyperfiltration in diabetic nephropathy].
Ito O; Ito S
Nihon Rinsho; 2005 Jun; 63 Suppl 6():331-5. PubMed ID: 15999729
[No Abstract] [Full Text] [Related]
34. Twelve shifting paradigms in diabetic renal disease and hypertension.
Mogensen CE
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897
[TBL] [Abstract][Full Text] [Related]
35. Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis.
Magee GM; Bilous RW; Cardwell CR; Hunter SJ; Kee F; Fogarty DG
Diabetologia; 2009 Apr; 52(4):691-7. PubMed ID: 19198800
[TBL] [Abstract][Full Text] [Related]
36. A differential diagnostic model of diabetic nephropathy and non-diabetic renal diseases.
Zhou J; Chen X; Xie Y; Li J; Yamanaka N; Tong X
Nephrol Dial Transplant; 2008 Jun; 23(6):1940-5. PubMed ID: 18156459
[TBL] [Abstract][Full Text] [Related]
37. Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.
Tonneijck L; Muskiet MH; Smits MM; van Bommel EJ; Heerspink HJ; van Raalte DH; Joles JA
J Am Soc Nephrol; 2017 Apr; 28(4):1023-1039. PubMed ID: 28143897
[TBL] [Abstract][Full Text] [Related]
38. Basal nitric oxide synthase activity is a major determinant of glomerular haemodynamics in humans.
Schlaich MP; Schmitt D; Ott C; Schmidt BM; Schmieder RE
J Hypertens; 2008 Jan; 26(1):110-6. PubMed ID: 18090547
[TBL] [Abstract][Full Text] [Related]
39. The effect of cyclooxygenase-2 inhibition on renal hemodynamic function in humans with type 1 diabetes.
Cherney DZ; Miller JA; Scholey JW; Bradley TJ; Slorach C; Curtis JR; Dekker MG; Nasrallah R; Hébert RL; Sochett EB
Diabetes; 2008 Mar; 57(3):688-95. PubMed ID: 18083781
[TBL] [Abstract][Full Text] [Related]
40. Progression of diabetic nephropathy in type 1 diabetic patients.
Najafian B; Mauer M
Diabetes Res Clin Pract; 2009 Jan; 83(1):1-8. PubMed ID: 19070384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
